LTGO-33 ( —— )

产品货号. M37510 CAS No. 2834106-06-6

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

LTGO-33
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

LTGO-33 is a species-specific inhibitor of the voltage-gated sodium channel NaV1.8, inhibiting NaV1.8, NaV1.1-NaV1.7, and NaV1.9.LTGO-33 inhibits wild-type and multiple NaV1.8 variants associated with human pain disorders and can be used for the study of pain.hBChE-IN-2 is a low affinity Nurr1 agonist.
产品描述

LTGO-33 is a species-specific inhibitor of the voltage-gated sodium channel NaV1.8, inhibiting NaV1.8, NaV1.1-NaV1.7, and NaV1.9.LTGO-33 inhibits wild-type and multiple NaV1.8 variants associated with human pain disorders and can be used for the study of pain.hBChE-IN-2 is a low affinity Nurr1 agonist.
体外实验

——
体内实验

——
同义词

——
通路

Membrane Transporter/Ion Channel
靶点

Sodium Channel
受体

Sodium Channel
研究领域

——
适应症

——

CAS Number

2834106-06-6
分子量

467.44
分子式

C21H17F4N3O3S
纯度

>98% (HPLC)
溶解度

——
SMILES

C[S@@](C1=CC=CC(NC(C2=C(N=CC(C(F)(F)F)=C2)OC3=C(C=C(C=C3)F)C)=O)=C1)(=N)=O
化学全称

——

计算器

产品手册

关联产品

ABBV-318

ABBV-318 是一种有效的 Nav1.7/ Nav1.8 阻滞剂，抑制 hNav1.7 和 hNav1.8 的 IC50 值分别为 2.8 μM 和 3.8 μM。ABBV-318 可以用于疼痛相关研究。
Bupivacaine

Bupivacaine 是一种 NMDA 受体抑制剂。Bupivacaine 可以阻断钠、L-钙和钾通道。Bupivacaine 有效阻断 SCN5A 通道，IC50 为 69.5 μM。Bupivacaine 可用于慢性疼痛的研究。
E 0747

E 0747 (E0747) is a new antiarrhythmic compound that inhibits arrhythmias by inhibiting Na channels in cardiac cells.